Neuroscience, Journal Year: 2023, Volume and Issue: 550, P. 102 - 113
Published: Dec. 4, 2023
Language: Английский
Neuroscience, Journal Year: 2023, Volume and Issue: 550, P. 102 - 113
Published: Dec. 4, 2023
Language: Английский
Journal of Nanobiotechnology, Journal Year: 2023, Volume and Issue: 21(1)
Published: Feb. 28, 2023
Blood-brain barrier (BBB) disruption is a major adverse event after ischemic stroke (IS). Caveolin-1 (Cav-1), scaffolding protein, played multiple roles in BBB permeability IS, while the pros and cons of Cav-1 on remain controversial. Numerous studies revealed that extracellular vesicles (EVs), especially stem cells derived EVs, exerted therapeutic efficacy IS; however, mechanisms needed to be clearly illustrated. Herein, we compared protective integrity between bone marrow mesenchymal (BMSC-EVs) EVs from brain endothelial (BEC-EVs) acute IS investigated whether mechanism was associated with antagonizing Cav-1-dependent tight junction proteins endocytosis.BMSC-EVs BEC-EVs were isolated characterized by nanoparticle tracking analysis, western blotting, transmission electron microscope. Oxygen glucose deprivation (OGD) treated b. End3 utilized evaluate cell leakage. CCK-8 TRITC-dextran leakage assays used measure viability transwell monolayer permeability. Permanent middle cerebral artery occlusion (pMCAo) model established, intravenously administered rats. Animal neurological function tests applied, microvessels cortex. analyzed Evans Blue (EB) staining respectively. Co-IP assay siRNA/pcDNA 3.1 vector transfection employed verify endocytosis proteins.Both kinds similar efficacies reducing infarction volume enhancing expressions ZO-1 Claudin-5 24 h pMCAo At same time, BMSC-EVs outstanding ameliorating function. Simultaneously, both treatments suppressed highly expressed OGD-exposed microvessels, this more prominent administration. knockdown reduced OGD-treated recovered expressions, whereas overexpression aggravated enhanced colocalization Claudin-5. Furthermore, partly reversed lower administrations cells.Our results demonstrated stroke, antagonistic endocytosis. treatment superior suppression amelioration.
Language: Английский
Citations
60Translational Stroke Research, Journal Year: 2022, Volume and Issue: 13(5), P. 665 - 675
Published: Jan. 15, 2022
Language: Английский
Citations
42International Journal of Nanomedicine, Journal Year: 2024, Volume and Issue: Volume 19, P. 1451 - 1467
Published: Feb. 1, 2024
Background: Ischemic stroke (IS) causes tragic death and disability worldwide. However, effective therapeutic interventions are finite. After IS, blood–brain barrier (BBB) integrity is disrupted, resulting in deteriorating neurological function. As a novel therapeutic, extracellular vesicles (EVs) have shown ideal restorative effects on BBB post-stroke; however, the definite mechanisms remain ambiguous. In present study, we investigated curative of EVs derived from bone marrow mesenchymal stem cells brain endothelial (BMSC-EVs BEC-EVs) after acute IS. Methods: were isolated BMSCs BECs, effect vitro oxygen-glucose deprivation (OGD) insulted BECs model vivo rat middle cerebral artery occlusion (MCAo) model. The cell monolayer leakage, tight junction expression, metalloproteinase (MMP) activity evaluated, infarct volume function also analyzed. Results: administration two kinds not only enhanced ZO-1 Occludin expressions but reduced permeability MMP-2/9 OGD-insulted BECs. amelioration infarction, deficits, increasing levels, as well MMP inhibition was observed MCAo rats. Additionally, increased levels Caveolin-1, CD147, vascular growth factor receptor 2 (VEGFR2), A (VEGFA) microvessels downregulated treatment. vitro, employment Caveolin-1 CD147 siRNA partly suppressed VEGFR2, VEGFA leakage OGD expressions. Conclusion: Our study firstly demonstrates that BEC BMSC-EVs administrations maintain via suppression Caveolin-1/CD147/VEGFR2/MMP pathway efficacy superior to BEC-EVs. Keywords: vesicles, ischemic stroke, matrix metalloproteinase, blood-brain
Language: Английский
Citations
9Biomolecules, Journal Year: 2024, Volume and Issue: 14(3), P. 378 - 378
Published: March 20, 2024
Ischemic stroke is a fatal and disabling disease worldwide imposes significant burden on society. At present, biological markers that can be conveniently measured in body fluids are lacking for the diagnosis of ischemic stroke, there no effective treatment methods to improve neurological function after stroke. Therefore, new ways diagnosing treating urgently needed. The neurovascular unit, composed neurons, astrocytes, microglia, other components, plays crucial role onset progression Extracellular vesicles nanoscale lipid bilayer secreted by various cells. key extracellular vesicles, which released cells unit serve as facilitators cellular communication, has been extensively documented recent literature. Here, we highlight unit-derived current status vesicle engineering treatment, problems encountered clinical translation therapies. derived from could provide an important contribution diagnostic therapeutic tools future, more studies this area should carried out.
Language: Английский
Citations
6European journal of medical research, Journal Year: 2023, Volume and Issue: 28(1)
Published: Nov. 6, 2023
Abstract Bacterial-derived extracellular vesicles (EVs) have emerged as crucial mediators in the cross-talk between hosts and pathogens, playing a significant role infectious diseases cancers. Among these Helicobacter pylori ( H. ) is particularly important bacterium implicated various gastrointestinal disorders, gastric cancers, systemic illnesses. achieves effects by stimulating host cells to secrete EVs generating internal outer membrane (OMVs). The derived from -infected modulate inflammatory signaling pathways, thereby affecting cell proliferation, apoptosis, cytokine release, immune modification, endothelial dysfunction, well disrupting cellular junctional structures inducing cytoskeletal reorganization. In addition, OMVs isolated play pivotal shaping subsequent immunopathological responses. These incite both immunosuppressive reactions within environment, facilitating pathogen evasion of defenses invasion cells. Despite this growing understanding, research involving -derived remains its early stages across different domains. comprehensive review, we present recent advancements elucidating contributions EV components, such non-coding RNAs (ncRNAs) proteins, pathogenesis extragastric diseases. Furthermore, highlight their potential utility biomarkers, therapeutic targets, vehicles for targeted delivery.
Language: Английский
Citations
16Colloids and Surfaces B Biointerfaces, Journal Year: 2024, Volume and Issue: 239, P. 113938 - 113938
Published: May 3, 2024
Language: Английский
Citations
5International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(7), P. 3130 - 3130
Published: March 28, 2025
Although thrombolytic therapy has enjoyed relative success, limitations remain, such as a narrow therapeutic window and inconsistent efficacy. Consequently, there is pressing need to develop novel approaches. In recent years, extracellular vesicles (EVs) have garnered increasing attention potential alternative stem cell therapy. Because of their ability cross the blood-brain barrier exert neuroprotective effects in cerebral ischemia hemorrhage, exploration EVs for clinical application stroke treatment expanding. are characterized by high heterogeneity, with composition closely mirroring that parent cells. This property enables distinguish between thus facilitating more rapid accurate diagnosis. Additionally, can be engineered carry specific molecules, miRNAs, targeting them cells, potentially enhancing outcome improving prognosis. this review, we will also explore methodologies isolation extraction EVs, critically evaluating advantages disadvantages various commonly employed separation techniques. Furthermore, briefly address current EV preservation administration methods, providing comprehensive overview state EV-based therapies treatment.
Language: Английский
Citations
0Molecular Neurobiology, Journal Year: 2025, Volume and Issue: unknown
Published: April 21, 2025
Language: Английский
Citations
0Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2023, Volume and Issue: 397(5), P. 2651 - 2679
Published: Nov. 15, 2023
Language: Английский
Citations
9Stem Cell Reviews and Reports, Journal Year: 2022, Volume and Issue: 19(2), P. 285 - 308
Published: Sept. 29, 2022
Language: Английский
Citations
13